17-10309305-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The ENST00000252172.9(MYH13):c.5098G>A(p.Glu1700Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
MYH13
ENST00000252172.9 missense
ENST00000252172.9 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 6.08
Genes affected
MYH13 (HGNC:7571): (myosin heavy chain 13) Predicted to enable microfilament motor activity. Predicted to be involved in muscle contraction. Predicted to act upstream of or within cellular response to starvation. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.825
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH13 | NM_003802.3 | c.5098G>A | p.Glu1700Lys | missense_variant | 35/41 | ENST00000252172.9 | NP_003793.2 | |
LOC107985004 | XR_007065617.1 | n.96-8193C>T | intron_variant, non_coding_transcript_variant | |||||
LOC107985004 | XR_001752791.3 | n.96-8193C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH13 | ENST00000252172.9 | c.5098G>A | p.Glu1700Lys | missense_variant | 35/41 | 1 | NM_003802.3 | ENSP00000252172 | P1 | |
MYH13 | ENST00000621918.1 | c.5098G>A | p.Glu1700Lys | missense_variant | 33/39 | 1 | ENSP00000480864 | P1 | ||
ENST00000609088.1 | n.95-8193C>T | intron_variant, non_coding_transcript_variant | 4 | |||||||
MYH13 | ENST00000418404.8 | c.5098G>A | p.Glu1700Lys | missense_variant | 34/40 | 5 | ENSP00000404570 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152266
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248252Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134938
GnomAD3 exomes
AF:
AC:
5
AN:
248252
Hom.:
AF XY:
AC XY:
1
AN XY:
134938
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461578Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727086
GnomAD4 exome
AF:
AC:
10
AN:
1461578
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
727086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74392
GnomAD4 genome
AF:
AC:
1
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | The c.5098G>A (p.E1700K) alteration is located in exon 35 (coding exon 33) of the MYH13 gene. This alteration results from a G to A substitution at nucleotide position 5098, causing the glutamic acid (E) at amino acid position 1700 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;H;H
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D
REVEL
Pathogenic
Sift
Uncertain
.;.;D
Sift4G
Uncertain
D;D;D
Polyphen
P;P;P
Vest4
MutPred
Gain of ubiquitination at E1700 (P = 0.0128);Gain of ubiquitination at E1700 (P = 0.0128);Gain of ubiquitination at E1700 (P = 0.0128);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at